Late-breaking data from the Phase III RISE trial further strengthen the well-established efficacy and safety profile of Qutenza®. Post-surgical neuropathic pain is a debilitating complication of surgery affecting millions of patients every year.1 AACHEN, Germany, Oct. 27, 2026...
Hence then, the article about grunenthal presents phase iii results for qutenza in post surgical neuropathic pain at iasp 2026 world congress on pain was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Grünenthal presents Phase III results for Qutenza® in post-surgical neuropathic pain at IASP 2026 World Congress on Pain )
Also on site :
- Liverpool vs Chelsea: Kick-Off Time, TV Channels, Live Stream and English League Cup Preview
- ‘You Can See Everything’ Ruled Ineligible for DGA Feature Prize, Will Compete Only in Documentary Category
- McDonald’s Is Launching 5 New Holiday Drinks, Including a Red Bull Cranberry Energizer